[1]
V. RIVERA TERÁN, C. Isnardi, P. De Abreu, I. Laurindo, and D. Alpízar Rodríguez, “OVERLIFE OF BIOLOGIC AND SYNTHETIC TARGETED DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE LATIN AMERICAN COUNTRIES”., Invest. Discapacidad, vol. 11, no. S1, Nov. 2025.